Tag: anti thyroid drugs industry

  • Top Trends Driving Innovation and Change in the Anti-Thyroid Drugs Market: Raising Awareness And Promoting Thyroid Health In The Anti-Thyroid Drug Market

    Top Trends Driving Innovation and Change in the Anti-Thyroid Drugs Market: Raising Awareness And Promoting Thyroid Health In The Anti-Thyroid Drug Market

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    How Has the Anti-Thyroid Drugs Market Growth Performance Trended Historically, And What Lies Ahead?

    In recent times, the market size of anti-thyroid drugs has experienced a slight increase. The predictions place this value to increase from $2.46 billion in 2024, to $2.49 billion in 2025, with a CAGR of 1.2%. Factors contributing to this growth during the historical period include the high occurrence of thyroid disorders, advancements in the development of drugs, and the quality of healthcare infrastructure.

    It is projected that the anti-thyroid drugs market will experience consistent growth in the coming years, with its value anticipated to reach $2.76 billion by 2029, increasing at a compound annual growth rate of 2.6%. Elements contributing to this growth throughout the predicted period include increased patient awareness and education, health care spending, demographic factors of patients, and worldwide economic conditions. Key trends predicted for this period encompass alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, as well as the utilization of telemedicine and remote monitoring.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

    What External and Internal Drivers Are Contributing to the Growth of theAnti-Thyroid Drugs Market?

    The prevalence of Graves’ disease, a direct cause of hyperthyroidism, is on the rise. The US-based National Library of Medicine, managed by the federal government, states that in developed nations, Graves’ disease is the primary cause of hyperthyroidism. It typically affects individuals aged between 30 and 60 and is seen 5–10 times more often in women than in men. Genetic factors contribute to about 79% of the risk for this disease, and environmental elements account for the remaining 21%. The growing incidence of Graves’ disease means an increase in the number of hyperthyroidism cases. In turn, this escalates the demand for anti-thyroid medications, thus stimulating market growth.

    What Segment Types Define the Anti-Thyroid Drugs Market Structure?

    The anti-thyroid drugs market covered in this report is segmented –

    1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

    2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

    3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

    Subsegments:

    1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

    2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

    Which Geographic Areas Hold the Strongest Growth Potential in the Anti-Thyroid Drugs Market?

    North America was the largest region in the anti-thyroid drugs market in 2024. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Long-Term Trends Are Transforming the Competitive Landscape of the Anti-Thyroid Drugs Market?

    Organizations dedicated to thyroid health are putting forth efforts to increase understanding of thyroid diseases, advancements in treatment options, and summaries of various studies about these disorders. In the United States, approximately 60% of hyperthyroidism sufferers are not aware of their condition and go untreated. To address this, organizations such as the American Thyroid Association (ATA) are educating the public about thyroid diseases. In a similar effort, the Thyroid Foundation of Canada is also working to raise public awareness and interest in thyroid disorders, including hyperthyroidism. Other organizations embarking on similar awareness campaigns include the American Academy of Otolaryngology and the British Thyroid Foundation, among others.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

    What Is the Definition of the Anti-Thyroid Drugs Market?

    Anti-thyroid drugs refer to agents that function by preventing the manufacture of thyroid hormones or by reducing the action of thyroid hormones. Additionally, they are suggested for use in radioactive iodine uptake tests to assess thyroid function and safeguard the thyroid gland in case of radiation exposure.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Anti-Thyroid Drugs Market to Reach $2.78 Billion by 2029 | Key Drivers and Future Outlook

    Anti-Thyroid Drugs Market to Reach $2.78 Billion by 2029 | Key Drivers and Future Outlook

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Estimated Market Size of the Anti-Thyroid Drugs Market In 2029?

    The market for anti-thyroid drugs has experienced steady growth in the past few years. It is expected to increase from $2.44 billion in 2024 to a value of $2.5 billion in 2025, representing a compound annual growth rate (CAGR) of 2.2%. This growth during the historical period can be traced back to the increasing occurence of thyroid disorders, developments in drug creation and enhancements in healthcare infrastructure.

    What Growth Rate Is Forecasted for the Anti-Thyroid Drugs Market by 2029?

    Expectations are set for the anti-thyroid drugs market size to experience consistent growth over the next few years. The market is predicted to hit the $2.78 billion mark by 2029, boasting a compound annual growth rate (CAGR) of 2.7%. This anticipated growth in the forecast period can be credited to factors such as patient education and awareness, healthcare expenditure, patient demographics, and the world’s economic conditions. Major advancements projected during this period encompass alternatives to thyroid surgery and radioactive iodine, patient-oriented care, and the rise of telemedicine and remote monitoring.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

    Which Key Companies Are Shaping the Future of the Anti-Thyroid Drugs Market?

    Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

    Which Factors Are Driving Demand in the Anti-Thyroid Drugs Industry?

    Hyperthyroidism, in numerous instances, is directly associated with Graves’ disease, which is showing a growing prevalence trend. As per the National Library of Medicine, a biomedical library run by the US federal government, Graves’ disease (GD) is the primary cause of hyperthyroidism in developed nations. This disease is predominantly experienced in the age group of 30 to 60, with women proving to be 5–10 times more susceptible than men. The risk of developing GD can largely be attributed to genetic factors, with a 79% likelihood, while environmental elements contribute around 21% to the risk. The tremendous increase in the occurrence of Graves’ disease has led to a rise in hyperthyroidism cases. This leads to a boost in demand for anti-thyroid medications, thereby aiding the market’s growth.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

    How Is the Anti-Thyroid Drugs Market Segmented by Several Divisions?

    The anti-thyroid drugs market covered in this report is segmented –

    1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

    2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

    3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

    Subsegments:

    1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

    2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

    What are the Emerging Market Trends Driving the Growth of the Anti-Thyroid Drugs Industry?

    Organizations dedicated to thyroid care are initiating measures to expand awareness of thyroid disorders, recent treatment advancements, and various thyroid disorder research findings. In the United States, around 60% of those with hyperthyroidism are unaware of their condition and remain without a diagnosis. The American Thyroid Association (ATA) and other associations are addressing these concerns by raising awareness about thyroid disorders. The Thyroid Foundation of Canada is also taking steps to increase public knowledge and understanding of thyroid diseases, including hyperthyroidism. Among others initiating awareness initiatives and programs are the American Academy of Otolaryngology and the British Thyroid Foundation.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

    Which Regions Are Driving Growth in the Anti-Thyroid Drugs Market?

    North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

    This Report Delivers Insight On:

    1. How big is the anti-thyroid drugs market, and how is it changing globally?

    2. Who are the major companies in the anti-thyroid drugs market, and how are they performing?

    3. What are the key opportunities and risks in the anti-thyroid drugs market right now?

    4. Which products or customer segments are growing the most in the anti-thyroid drugs market?

    5. What factors are helping or slowing down the growth of the anti-thyroid drugs market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 2071930708

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Anti-Thyroid Drugs Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

    Anti-Thyroid Drugs Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    How Are Key Drivers Contributing to the Growth and Expansion of the Anti-Thyroid Drugs Market?

    Graves’ disease, a primary cause of hyperthyroidism, is also increasing in incidence, further contributing to the demand for anti-thyroid drugs. According to the National Library of Medicine, Graves’ disease is more prevalent in women and typically affects individuals between the ages of 30 and 60. With genetic factors accounting for a large portion of the risk, the growing number of Graves’ disease cases will increase the need for anti-thyroid medications.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

    #What is the Projected CAGR for the Anti-Thyroid Drugs Market Size from 2025 to 2034?

    The anti-thyroid drugs market has witnessed consistent growth in recent years. It is projected to rise from $2.44 billion in 2024 to $2.5 billion in 2025, with a compound annual growth rate (CAGR) of 2.2%. This growth in the past has been influenced by the widespread presence of thyroid disorders, improvements in pharmaceutical development, and advancements in healthcare infrastructure.

    The anti-thyroid drugs market is expected to grow steadily, reaching $2.78 billion by 2029 at a CAGR of 2.7%. The growth is influenced by patient awareness, healthcare expenditure, demographics, and global economic conditions. Major trends include thyroid surgery and radioactive iodine alternatives, patient-centric care, and the adoption of telemedicine and remote monitoring.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

    What New Market Trends Are Reshaping theAnti-Thyroid Drugs Market and Its Opportunities?

    Organizations focused on thyroid care are ramping up awareness initiatives to address the high rate of undiagnosed thyroid disorders. Associations such as the American Thyroid Association (ATA) and the Thyroid Foundation of Canada are launching educational campaigns to inform the public and improve early detection of conditions like hyperthyroidism.

    Who Are the Leading Market Players Fueling Growth in the Anti-Thyroid Drugs Market Trend?

    Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

    How is the Global Anti-Thyroid Drugs Market Segemented?

    The anti-thyroid drugs market covered in this report is segmented –

    1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

    2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

    3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

    Subsegments:

    1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

    2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=3401&type=smp

    Which Geographics are Influencing the Growth of the Anti-Thyroid Drugs Market?

    North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Global Anti-Thyroid Drugs Market 2025, By The Business Research Company:

    Diuretics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

    Genito-Urinary Drugs Global Market Report 2022

    https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

    Drugs for Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Anti-Thyroid Drugs Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Anti-Thyroid Drugs Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the anti-thyroid drugs market grown in recent years?

    In recent years, there has been a consistent expansion in the size of the anti-thyroid drugs market. The market, which is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 2.2%. The previous period’s growth can be credited to the widespread incidence of thyroid disorders, advancements in medicine creation, and the development of healthcare structures.

    How is the anti-thyroid drugs market size expected to evolve during the forecast period?

    The market size for anti-thyroid drugs is forecasted to exhibit solid expansion in the coming years, reaching a value of $2.78 billion in 2029 with a CAGR of 2.7%. This growth during the predicted timeframe can be credited to factors such as increased patient awareness and education, healthcare spending, patient demographics, and worldwide economic conditions. Notably, the period is expected to see major trends such as alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, and the adoption of telemedicine and remote monitoring.

    Get your anti-thyroid drugs market report here!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

    Which key drivers are propelling the anti-thyroid drugs market’s growth?

    The rise in cases of Graves’ disease, which is an immediate cause of hyperthyroidism, has been observed. The US-based National Library of Medicine, owned by the United States federal government, states that Graves’ disease (GD) is the leading cause of hyperthyroidism in developed nations. GD is typically prevalent among those aged between 30 and 60, with women being 5-10 times more vulnerable than men. A 79% genetic predisposition is related to the risk for GD, while 21% is attributable to environmental factors. The rise in Graves’ disease cases is causing an increase in hyperthyroidism sufferers. This has led to a surge in demand for anti-thyroid drugs, thereby propelling the market’s growth.

    What are the market segments in the anti-thyroid drugs industry?

    The anti-thyroid drugs market covered in this report is segmented –

    1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

    2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

    3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

    Subsegments:

    1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

    2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

    Which leading companies are shaping the growth of the anti-thyroid drugs market?

    Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

    What key trends are currently impacting the anti-thyroid drugs market’s development?

    Organizations dedicated to thyroid health are stepping up efforts to promote knowledge on thyroid conditions, the latest therapy options, and recent findings in thyroid disorder research. It’s estimated that around 60% of hyperthyroidism sufferers in the USA are undiagnosed and uninformed about their condition. To tackle this problem, several associations such as the American Thyroid Association (ATA) have embarked on educational campaigns about thyroid disorders. Likewise, the Thyroid Foundation of Canada is taking measures to raise public curiosity and consciousness about thyroid diseases, including hyperthyroidism. Other bodies, like the American Academy of Otolaryngology and the British Thyroid Foundation, are implementing awareness and outreach initiatives too.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3401

    Which geographic areas are influencing the growth of the anti-thyroid drugs market?

    North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Diuretics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

    Genito-Urinary Drugs Global Market Report 2022

    https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

    Drugs for Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth, Trends, and Opportunities in the Anti-Thyroid Drugs Market: Key Insights for the Next Decade

    Growth, Trends, and Opportunities in the Anti-Thyroid Drugs Market: Key Insights for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Long-Term Projected Growth Rate for the Anti-Thyroid Drugs Market, and What Are the Key Drivers?

    In recent years, there has been a consistent expansion in the size of the anti-thyroid drugs market. The market, which is projected to increase from $2.44 billion in 2024 to $2.5 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 2.2%. The previous period’s growth can be credited to the widespread incidence of thyroid disorders, advancements in medicine creation, and the development of healthcare structures.

    The market size for anti-thyroid drugs is forecasted to exhibit solid expansion in the coming years, reaching a value of $2.78 billion in 2029 with a CAGR of 2.7%. This growth during the predicted timeframe can be credited to factors such as increased patient awareness and education, healthcare spending, patient demographics, and worldwide economic conditions. Notably, the period is expected to see major trends such as alternatives to thyroid surgery and radioactive iodine, a focus on patient-oriented care, and the adoption of telemedicine and remote monitoring.

    Which Macro and Microeconomic Factors Are Accelerating the Growth of the Anti-Thyroid Drugs Market?

    The rise in cases of Graves’ disease, which is an immediate cause of hyperthyroidism, has been observed. The US-based National Library of Medicine, owned by the United States federal government, states that Graves’ disease (GD) is the leading cause of hyperthyroidism in developed nations. GD is typically prevalent among those aged between 30 and 60, with women being 5-10 times more vulnerable than men. A 79% genetic predisposition is related to the risk for GD, while 21% is attributable to environmental factors. The rise in Graves’ disease cases is causing an increase in hyperthyroidism sufferers. This has led to a surge in demand for anti-thyroid drugs, thereby propelling the market’s growth.

    Request Your Free Anti-Thyroid Drugs Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3401&type=smp

    Which Companies Are Leading the Charge in Expanding the Anti-Thyroid Drugs Market?

    Major companies operating in the anti-thyroid drugs market include Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc, Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc, RLC LABS Inc., Amgen Inc., Lannett Company Inc., Sanofi S.A., Novartis AG, Teva Pharmaceutical Industries Ltd., Eli Lilly and Company, Aspen Pharmacare Holdings Limited, Astellas Pharma Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Limited, Roche Holding AG, Bayer AG, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Lupin Limited, Cadila Healthcare Limited, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Akorn Inc.

    What New Trends Are Reshaping the Anti-Thyroid Drugs Market and Its Opportunities?

    Organizations dedicated to thyroid health are stepping up efforts to promote knowledge on thyroid conditions, the latest therapy options, and recent findings in thyroid disorder research. It’s estimated that around 60% of hyperthyroidism sufferers in the USA are undiagnosed and uninformed about their condition. To tackle this problem, several associations such as the American Thyroid Association (ATA) have embarked on educational campaigns about thyroid disorders. Likewise, the Thyroid Foundation of Canada is taking measures to raise public curiosity and consciousness about thyroid diseases, including hyperthyroidism. Other bodies, like the American Academy of Otolaryngology and the British Thyroid Foundation, are implementing awareness and outreach initiatives too.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/anti-thyroid-drugs-global-market-report

    Which Key Market Segments Comprise the Anti-Thyroid Drugs Market and Drive Its Revenue Growth?

    The anti-thyroid drugs market covered in this report is segmented –

    1) By Drug Type: Thionamides (Inhibition Of Hormone Synthesis), Iodides (Inhibition Of Hormone Release)

    2) By Route of Administration: Oral, Intravenous, Other Route Of Administration

    3) By Distribution Channel: Wholesaler Or Distributors, Retail Chain, Online Distribution, Other Distribution Channels

    Subsegments:

    1) By Thionamides (Inhibition Of Hormone Synthesis): Methimazole, Propylthiouracil

    2) By Iodides (Inhibition Of Hormone Release): Potassium Iodide, Lugol’s Iodine Solution

    What Are the Top Regions Fueling Growth in the Anti-Thyroid Drugs Market?

    North America was the largest region in the anti-thyroid drugs market in 2023. The Middle East is expected to be the fastest-growing region in the anti-thyroid drugs market during the forecast period. The regions covered in the anti-thyroid drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Defines the Scope of the Anti-Thyroid Drugs Market?

    Anti-thyroid drugs refer to agents that function by preventing the manufacture of thyroid hormones or by reducing the action of thyroid hormones. Additionally, they are suggested for use in radioactive iodine uptake tests to assess thyroid function and safeguard the thyroid gland in case of radiation exposure.

    Browse Through More Similar Reports By The Business Research Company:

    Diuretics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report

    Genito-Urinary Drugs Global Market Report 2022

    https://www.thebusinessresearchcompany.com/report/genito-urinary-drugs-global-market-report

    Drugs for Immunotherapy Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: